Results 1–20 of 150 for evusheld in the 'Written Answers'

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Lord Mendelsohn: ...Majesty's Government what papers and data were consulted in advance of the Secretary of State for Health and Social Care and Chief Medical Officer taking the decision not to pursue procurement of Evusheld; and what is the most recent real time evidence of Evusheld’s effectiveness that they have consulted.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Lord Mendelsohn: ...Majesty's Government what plans they have to undertake an equalities assessment on the availability of protection from COVID-19, given that immunocompromised and vulnerable patients' only access to Evusheld costs up to £3,000 on the private market.

Written Answers — Department of Health and Social Care: Coronavirus: Vaccination (28 Nov 2022)

Lord Markham: ...expertise in the therapeutic options available and consults experts in an NHS expert working group and the Prophylaxis Oversight Group. The Chief Medical Officer for England has agreed that Evusheld should be referred to the National Institute for Health and Care Excellence for further evaluation, which is underway

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government what assessment they have made of the number of immunocompromised people in England who could potentially benefit from Evusheld if it is found to be appropriate for prescription on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government why, given that Evusheld has been approved for private prescription, it has not yet been approved for prescription on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (28 Nov 2022)

Baroness Whitaker: To ask His Majesty's Government when they expect a decision to be made as to the suitability of prescribing Evusheld on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether a recommendation by Rapid C-19 is stopping the provision of Evusheld in the NHS by Christmas.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether Evusheld will be available to NHS patients before Christmas.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether they will rule out the possibility that patients will receive a placebo in place of Evusheld.

Written Answers — Department of Health and Social Care: Evusheld (22 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government what discussions they have had with experts in any of the 32 countries using Evusheld on their real time testing and trials.

Written Answers — Department of Health and Social Care: Evusheld (18 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, how many members of the RAPID C-19 Oversight Group were (1) full time clinicians or doctors, and (2) clinicians who treat immunocompromised patients.

Written Answers — Department of Health and Social Care: Evusheld (16 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government why a commissioning recommendation by NICE on Evusheld takes nearly a year to make; and whether they will expedite the appraisal of Evusheld by NICE by allocating it increased resources so the decision is made before 25 December.

Written Answers — Department of Health and Social Care: Evusheld (16 Nov 2022)

Lord Mendelsohn: ...patients (a) who got COVID-19, (b) have been admitted to hospital with COVID-19, (c) who were admitted to intensive care with COVID-19, and (d) have died from COVID-19, since 17 March when Evusheld was approved for use in England.

Written Answers — Department of Health and Social Care: Evusheld (10 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government, further to the report RAPID C-19 Oversight Group report: review of Evusheld by the RAPID C-19 Oversight Group, published on 6 October, whether they will (1) consult a wider group with more diverse viewpoints and expertise to make a recommendation on the efficacy of Evusheld, and (2) engage other committees with expertise like SAGE and the JCVI on this treatment.

Written Answers — Department of Health and Social Care: Evusheld (8 Nov 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with the Centre for Disease Control in the US on their use of Evusheld as a pre-exposure prophylaxis to prevent Covid-19 in people who are moderately to severely immunocompromised.

Written Answers — Department of Health and Social Care: Evusheld (8 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government whether they have entered negotiations with AstraZeneca in relation to the cost of procuring Evusheld.

Written Answers — Department of Health and Social Care: Evusheld (8 Nov 2022)

Lord Mendelsohn: ...with representatives of the 125 expert clinicians from all four nations of the UK covering 17 relevant medical disciplines and advising the APPG Vulnerable Groups to Pandemics on the efficacy of Evusheld.

Written Answers — Department of Health and Social Care: Evusheld (8 Nov 2022)

Lord Mendelsohn: To ask His Majesty's Government when they expect the NICE assessment of Evusheld to be completed; and whether, if approved, the treatment will be provided for patients in England this winter.

Written Answers — Department of Health and Social Care: Evusheld (7 Nov 2022)

Lord Mendelsohn: ...Majesty's Government what consultation process took place which led to the decision by the Secretary of State for Health and Social Care and the Chief Medical Officer not to pursue procurement of Evusheld; whether they will publish minutes of the meeting where this decision was made; and who attended that meeting.

Written Answers — Department of Health and Social Care: Evusheld (3 Nov 2022)

Zarah Sultana: To ask the Secretary of State for Health and Social Care, when she expects the National Institute for Health and Care Excellence to conclude its appraisal of Evusheld.


1 2 3 4 5 6 7 8 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.